Literature DB >> 18220279

The future is around the corner: Noninvasive diagnosis of progressive nonalcoholic steatohepatitis.

Ancha Baranova, Zobair M Younossi.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18220279     DOI： 10.1002/hep.22140

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  13 in total

1.  A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.

Authors:  Zobair M Younossi; Sandra Page; Nila Rafiq; Aybike Birerdinc; Maria Stepanova; Noreen Hossain; Arian Afendy; Zahra Younoszai; Zachary Goodman; Ancha Baranova
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

2.  Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis.

Authors:  Kento Imajo; Masato Yoneda; Koji Fujita; Takaomi Kessoku; Wataru Tomeno; Yuji Ogawa; Yoshiyasu Shinohara; Yusuke Sekino; Hironori Mawatari; Yuichi Nozaki; Hiroyuki Kirikoshi; Masataka Taguri; Gen Toshima; Junichiro Takahashi; Satoru Saito; Koichiro Wada; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

3.  Resistin expression correlates with steatohepatitis in morbidly obese patients.

Authors:  Claire R Edwards; A Katharine Hindle; Patricia S Latham; Sidney W Fu; Fred J Brody
Journal:  Surg Endosc       Date:  2012-12-12       Impact factor: 4.584

4.  Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.

Authors:  Zobair M Younossi; Rohit Loomba; Quentin M Anstee; Mary E Rinella; Elisabetta Bugianesi; Giulio Marchesini; Brent A Neuschwander-Tetri; Lawrence Serfaty; Francesco Negro; Stephen H Caldwell; Vlad Ratziu; Kathleen E Corey; Scott L Friedman; Manal F Abdelmalek; Stephen A Harrison; Arun J Sanyal; Joel E Lavine; Philippe Mathurin; Michael R Charlton; Zachary D Goodman; Naga P Chalasani; Kris V Kowdley; Jacob George; Keith Lindor
Journal:  Hepatology       Date:  2018-07       Impact factor: 17.425

5.  Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound.

Authors:  Trong N Nguyen; Anthony S Podkowa; Alex Y Tam; Eben C Arnold; Rita J Miller; Trevor H Park; Minh N Do; Michael L Oelze
Journal:  Ultrasound Med Biol       Date:  2019-05-08       Impact factor: 2.998

6.  Role of serum hyaluronic acid in predicting necroinflammatory activity of the nonalcoholic fatty liver disease.

Authors:  Hakan Guveli; Oya Ovunc Kurdas
Journal:  Hepatol Forum       Date:  2022-04-26

Review 7.  Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.

Authors:  Raj Vuppalanchi; Naga Chalasani
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

8.  Non alcoholic fatty liver disease and metabolic syndrome.

Authors:  P Paschos; K Paletas
Journal:  Hippokratia       Date:  2009-01       Impact factor: 0.471

9.  Systematic analysis of the gene expression in the livers of nonalcoholic steatohepatitis: implications on potential biomarkers and molecular pathological mechanism.

Authors:  Yida Zhang; Susan S Baker; Robert D Baker; Ruixin Zhu; Lixin Zhu
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

10.  Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example.

Authors:  Sandra Page; Aybike Birerdinc; Michael Estep; Maria Stepanova; Arian Afendy; Emanuel Petricoin; Zobair Younossi; Vikas Chandhoke; Ancha Baranova
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.